SCHEMBL4636895

SCHEMBL4636895

CCOC(=O)Cc1c(C)cc2cc(C(F)(F)F)ccn12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNN4 O15554 1/20 0.39
ALDH1A1 P00352 5/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
MAPT P10636 1/20 0.38
GRIN1 Q05586 2/20 0.37
GRIN2B Q13224 2/20 0.37
CACNA1F O60840 1/20 0.37
CACNA1D Q01668 1/20 0.37
CACNA1S Q13698 1/20 0.37
CACNA1C Q13936 1/20 0.37
ALOX15 P16050 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
GAA P10253 1/20 0.37
TRPV4 Q9HBA0 1/20 0.37
THRB P10828 1/20 0.37
HTT P42858 1/20 0.36
ATM Q13315 1/20 0.36
GRM5 P41594 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4635700 0.81 ALDH1A1 (0.40) ALDH1A1MEN1KMT2AMAPTALOX15
SCHEMBL4635494 0.78 L3MBTL1 (0.59) ALDH1A1MEN1KMT2AMAPTL3MBTL1
SCHEMBL3325939 0.78 PDCD1 (0.39) ALDH1A1MEN1KMT2AMAPTALOX15
SCHEMBL2770063 0.72 GSR (0.38) KCNN4ALDH1A1MEN1KMT2AMAPT
SCHEMBL24651096 0.72 POLB (0.45) ALDH1A1MEN1KMT2AMAPTL3MBTL1
SCHEMBL701131 0.72 ALDH1A1 (0.61) ALDH1A1MEN1KMT2AMAPTL3MBTL1
SCHEMBL1427075 0.69 L3MBTL1 (0.55) ALDH1A1MEN1KMT2AMAPTGRIN1
SCHEMBL17396753 0.69 L3MBTL1 (0.54) ALDH1A1MEN1KMT2AMAPTGRIN1
SCHEMBL23639582 0.68 KDM4E (0.50) ALDH1A1MEN1KMT2AMAPTL3MBTL1
SCHEMBL23218135 0.68 ANO1 (0.45) ALDH1A1MEN1KMT2AMAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080306109-A1 Indolizine Derivatives as Ligands of the Crth2 Receptor ARGENTA DISCOVERY LIMITED (GB) 2008-12-11 US disclosed
CN-101305001-A Indolizine derivatives as ligands of the CRTH2 receptor ARGENTA DISCOVERY LTD (GB) 2008-11-12 CN disclosed
EP-1931663-A1 IMDOLIZINE DERIVATIVES AS LIGANDS OF THE CRTH2 RECEPTOR Argenta Discovery Limited (GB) 2008-06-18 EP disclosed
WO-2007031747-A1 IMDOLIZINE DERIVATIVES AS LIGANDS OF THE CRTH2 RECEPTOR ARGENTA DISCOVERY LIMITED (GB) 2007-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080306109-A1 Indolizine Derivatives as Ligands of the Crth2 Receptor HRH4, HRH2, HRH3 KCNN4 1531/4885ALDH1A1 3463/4885MEN1 3938/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.